Cargando…
Technological Challenges and Future Issues for the Detection of Circulating MicroRNAs in Patients With Cancer
In the era of precision medicine, the success of clinical trials, notably for patients diagnosed with cancer, strongly relies on biomarkers with pristine clinical value but also on robust and versatile analytical technologies to ensure proper patients' stratification and treatment. In this revi...
Autores principales: | Cacheux, Jean, Bancaud, Aurélien, Leichlé, Thierry, Cordelier, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894013/ https://www.ncbi.nlm.nih.gov/pubmed/31850308 http://dx.doi.org/10.3389/fchem.2019.00815 |
Ejemplares similares
-
Circulating MicroRNAs in Cancer: Potential and Challenge
por: Cui, Mengying, et al.
Publicado: (2019) -
Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022) -
Circulating microRNAs in aging
por: Bonafè, Massimiliano, et al.
Publicado: (2015) -
Circulating microRNAs in Medicine
por: Pozniak, Tetiana, et al.
Publicado: (2022) -
µLAS: Sizing of expanded trinucleotide repeats with femtomolar sensitivity in less than 5 minutes
por: Malbec, Rémi, et al.
Publicado: (2019)